To evaluate the clinical and prognostic potential of LHCGR, patients with TGCTs (n = 216) were stratified according to tumor histology and subsequently sub-grouped according to serum levels of routinely used tumor markers: hCG, LDH, and AFP. Here, LHCGR is linked to neoplasm.